v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 2,130,758 $ 2,097,945
Accounts receivable, net of allowance for credit losses of $61,675 and $64,000, respectively 343,246 622,914
Inventory 243,285 158,362
Related party loans 18,669
Tax refund receivable 6,377
Other current assets 341,311 278,896
Deferred offering costs 136,025
Total current assets 3,058,600 3,319,188
Right of use assets – operating lease 1,917,563 883,029
Property and equipment, net of accumulated depreciation of $760,655 and $608,703, respectively 799,538 876,682
Security deposit 3,650
Total assets 5,775,701 5,082,549
Current Liabilities:    
Accounts payable 564,014 371,661
Accrued expenses 502,183 506,381
Corporate taxes payable 23,085 23,000
Deferred revenue 94,097
Right of use liability – operating lease 323,935 279,176
Total current liabilities 1,413,217 1,274,315
Right of use liability – operating lease 1,663,229 628,274
Derivative liability 371,216
Deferred tax liabilities 6,602
Total long-term liabilities 2,034,445 634,876
Total liabilities 3,447,662 1,909,191
Commitments and contingencies – Note 7
Stockholders’ Equity    
Preferred stock - authorized 10,000,000 shares, $0.001 par value; zero issued and outstanding as of December 31, 2025 and December 31, 2024
Common stock - authorized 190,000,000 shares, par value $0.001 par value; 4,858,663 issued and outstanding as of December 31, 2025 and 3,000,000 December 31, 2024 4,860 3,000
Additional paid in capital 12,583,193 5,464,006
Accumulated deficit (10,260,014) (2,293,648)
Total stockholders’ equity 2,328,039 3,173,358
Total liabilities and stockholders’ equity $ 5,775,701 $ 5,082,549